| Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin. | kidney, |
| An association between VHL inactivation, reduced Mad2 levels and increased aneuploidy was also found in renal cancer cells, implying that pVHL probably contribute to tumour suppression. | kidney, |
| Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness. | kidney, |
| Inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL) causes the most common form of kidney cancer. | kidney, |
| The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt. | kidney, |
| Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. | kidney, |
| cooperation of VHL and EAF2 may be critical for angiogenic regulation of the liver and prostate, and concurrent loss of these two tumor suppressors may result in a pro-angiogenic phenotype. | liver,prostate, |
| we show that pVHL, a tumor suppressor protein that has been implicated in the pathogenesis of renal cell carcinoma (RCC), plays an important role in regulation of cytokinesis. | kidney, |
| Studies indicate that inactivation of the VHL tumor suppressor gene is a frequent event in clear-cell renal carcinoma. | kidney, |
| Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells. | kidney, |
| Inactivation of the VHL tumor suppressor gene is an early, causal event in the development of clear cell renal cell carcinomas and is common in both hereditary and nonhereditary forms [review] | kidney, |
| Conditional inactivation of the mouse von Hippel-Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney. | kidney, |
| results confirmed that the existence of G allele in both rs779805 and rs1642742 in the von Hippel-Lindau tumor suppressor gene is of importance in renal cell carcinoma tumorigenesis | kidney, |
| Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model | liver, |
| Data show that 100% of von Hippel-Lindau tumor suppressor protein (Vhl) / polybromo 1 protein (Pbrm1) knockout mice developed renal cancers by 20 months of age. | kidney, |
| Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters | thyroid, |
| von Hippel-Lindau-like protein (VLP) is conserved in upper mammals and specifically expressed in brain and testis. Structural analysis and molecular dynamics simulations show VLP to be similar to von Hippel-Lindau tumor suppressor protein (pVHL) three-dimensional organization and binding dynamics. Conservation of elements at the protein interfaces suggests VLP to be a functional pVHL homolog possessing multiple functions. | brain, |
| Upregulation of miR-211 Promotes Chondrosarcoma Development via Targeting Tumor Suppressor VHL | sarcoma, |
| Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. | kidney, |
| Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. | lung, |